These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30475228)

  • 1. Compound haploinsufficiency of Dok2 and Dusp4 promotes lung tumorigenesis.
    Chen M; Zhang J; Berger AH; Diolombi MS; Ng C; Fung J; Bronson RT; Castillo-Martin M; Thin TH; Cordon-Cardo C; Plevin R; Pandolfi PP
    J Clin Invest; 2019 Jan; 129(1):215-222. PubMed ID: 30475228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DOK2 inhibits EGFR-mutated lung adenocarcinoma.
    Berger AH; Chen M; Morotti A; Janas JA; Niki M; Bronson RT; Taylor BS; Ladanyi M; Van Aelst L; Politi K; Varmus HE; Pandolfi PP
    PLoS One; 2013; 8(11):e79526. PubMed ID: 24255704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of DOK genes as lung tumor suppressors.
    Berger AH; Niki M; Morotti A; Taylor BS; Socci ND; Viale A; Brennan C; Szoke J; Motoi N; Rothman PB; Teruya-Feldstein J; Gerald WL; Ladanyi M; Pandolfi PP
    Nat Genet; 2010 Mar; 42(3):216-23. PubMed ID: 20139980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia.
    Downer EJ; Johnston DG; Lynch MA
    Mol Cell Neurosci; 2013 Sep; 56():148-58. PubMed ID: 23659921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Region-Specific Dok2 Overexpression Associates with Poor Prognosis in Human Astrocytoma.
    Deshpande RP; Chandra Sekhar YBVK; Panigrahi M; Babu PP
    Mol Neurobiol; 2018 Jan; 55(1):402-408. PubMed ID: 27975172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DOK2 as a marker of poor prognosis of patients with gastric adenocarcinoma after curative resection.
    Miyagaki H; Yamasaki M; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Takiguchi S; Fujiwara Y; Mori M; Doki Y
    Ann Surg Oncol; 2012 May; 19(5):1560-7. PubMed ID: 22130622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-trans retinoic acid induces p62DOK1 and p56DOK2 expression which enhances induced differentiation and G0 arrest of HL-60 leukemia cells.
    Lamkin TJ; Chin V; Yen A
    Am J Hematol; 2006 Aug; 81(8):603-15. PubMed ID: 16823827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Dusp4 and p53 loss with Dbf4 amplification drives tumorigenesis via cell cycle restriction and replication stress escape in breast cancer.
    Hanna A; Nixon MJ; Estrada MV; Sanchez V; Sheng Q; Opalenik SR; Toren AL; Bauer J; Owens P; Mason FM; Cook RS; Sanders ME; Arteaga CL; Balko JM
    Breast Cancer Res; 2022 Jul; 24(1):51. PubMed ID: 35850776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis.
    Nguyen MH; Koinuma J; Ueda K; Ito T; Tsuchiya E; Nakamura Y; Daigo Y
    Cancer Res; 2010 Jul; 70(13):5337-47. PubMed ID: 20551060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dok2 likely down-regulates Klf1 in mouse erythroleukemia cells.
    Tanaka Y; Kulkeaw K; Inoue T; Tan KS; Nakanishi Y; Shirasawa S; Sugiyama D
    Anticancer Res; 2014 Aug; 34(8):4561-7. PubMed ID: 25075100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis.
    Wu Q; Tian Y; Zhang J; Tong X; Huang H; Li S; Zhao H; Tang Y; Yuan C; Wang K; Fang Z; Gao L; Hu X; Li F; Qin Z; Yao S; Chen T; Chen H; Zhang G; Liu W; Sun Y; Chen L; Wong KK; Ge K; Chen L; Ji H
    Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E3978-E3986. PubMed ID: 29632194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of Livin inhibits tumorigenesis and metastasis via VEGF and MMPs pathway in lung cancer.
    Lin X; Li HR; Lin XF; Yu ME; Tu XW; Hua ZD; Lin M; Xu NL; Han LL; Chen YS
    Int J Oncol; 2015 Aug; 47(2):657-67. PubMed ID: 26094984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haplo-insufficiency: a driving force in cancer.
    Berger AH; Pandolfi PP
    J Pathol; 2011 Jan; 223(2):137-46. PubMed ID: 21125671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of dual-specificity phosphatase 4 enhances cell proliferation and invasiveness in colorectal carcinomas.
    Ichimanda M; Hijiya N; Tsukamoto Y; Uchida T; Nakada C; Akagi T; Etoh T; Iha H; Inomata M; Takekawa M; Moriyama M
    Cancer Sci; 2018 Jan; 109(1):250-258. PubMed ID: 29150975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sanguinarine inhibits growth and invasion of gastric cancer cells via regulation of the DUSP4/ERK pathway.
    Zhang R; Wang G; Zhang PF; Zhang J; Huang YX; Lu YM; Da W; Sun Q; Zhu JS
    J Cell Mol Med; 2017 Jun; 21(6):1117-1127. PubMed ID: 27957827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nimbolide suppresses non-small cell lung cancer cell invasion and migration via manipulation of DUSP4 expression and ERK1/2 signaling.
    Lin H; Qiu S; Xie L; Liu C; Sun S
    Biomed Pharmacother; 2017 Aug; 92():340-346. PubMed ID: 28554129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition.
    Cagnol S; Rivard N
    Oncogene; 2013 Jan; 32(5):564-76. PubMed ID: 22430215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dok1 and Dok2 Proteins Regulate Cell Cycle in Hematopoietic Stem and Progenitor Cells.
    Coppin E; De Grandis M; Pandolfi PP; Arcangeli ML; Aurrand-Lions M; Nunès JA
    J Immunol; 2016 May; 196(10):4110-21. PubMed ID: 27183638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NEDD9 promotes lung cancer metastasis through epithelial-mesenchymal transition.
    Jin Y; Li F; Zheng C; Wang Y; Fang Z; Guo C; Wang X; Liu H; Deng L; Li C; Wang H; Chen H; Feng Y; Ji H
    Int J Cancer; 2014 May; 134(10):2294-304. PubMed ID: 24174333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.